Market closed
Stereotaxis/$STXS
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Stereotaxis
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
Ticker
$STXS
Sector
Trading on
AMEX
Industry
Health Care Equipment & Supplies
Headquarters
Employees
122
Website
Stereotaxis Metrics
BasicAdvanced
$191M
-
-$0.27
1.55
-
Price and volume
Market cap
$191M
Beta
1.55
52-week high
$3.29
52-week low
$1.66
Average daily volume
403K
Financial strength
Current ratio
1.39
Quick ratio
0.897
Long term debt to equity
34.414
Total debt to equity
37.817
Management effectiveness
Return on assets (TTM)
-29.35%
Return on equity (TTM)
-106.46%
Valuation
Price to revenue (TTM)
7.531
Price to book
17.62
Price to tangible book (TTM)
-103.53
Price to free cash flow (TTM)
-15.477
Growth
Revenue change (TTM)
-14.79%
Earnings per share change (TTM)
0.62%
3-year revenue growth (CAGR)
-9.22%
3-year earnings per share growth (CAGR)
27.50%
What the Analysts think about Stereotaxis
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Stereotaxis stock.
Stereotaxis Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Stereotaxis Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Stereotaxis News
AllArticlesVideos
Stereotaxis Announces First GenesisX Robotic System Order
GlobeNewsWire·14 hours ago
Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter
GlobeNewsWire·4 days ago
Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Stereotaxis stock?
Stereotaxis (STXS) has a market cap of $191M as of January 31, 2025.
What is the P/E ratio for Stereotaxis stock?
The price to earnings (P/E) ratio for Stereotaxis (STXS) stock is 0 as of January 31, 2025.
Does Stereotaxis stock pay dividends?
No, Stereotaxis (STXS) stock does not pay dividends to its shareholders as of January 31, 2025.
When is the next Stereotaxis dividend payment date?
Stereotaxis (STXS) stock does not pay dividends to its shareholders.
What is the beta indicator for Stereotaxis?
Stereotaxis (STXS) has a beta rating of 1.55. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.